Gilead upped on HIV franchise; Merck downgraded on Keytruda LoE at Deutsche Bank
Gilead (GILD) stock won an upgrade from Deutsche Bank on HIV treatment boost, while Merck (MRK) stock received a downgrade on ...
Germany's Merck Appoints Chiefs of Life Science, Healthcare Business Sectors
The German pharmaceutical-and-chemicals company on Tuesday said it appointed Jean-Charles Wirth as new chief executive of life science. Wirth succeeds Matthias Heinzel, who decided to not renew his ...
Merck KGaA to replace two executives with company veterans
Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...
Deutsche downgrades Merck ahead of Keytruda 2028 expiration
Deutsche Bank analyst James Shin downgraded Merck (MRK) to Hold from Buy with a price target of $105, down from $128. The firm believes the ...